INmune Bio Inc. Common stock

INMBNASDAQUSD
2.43 USD
0.07 (2.97%)AT CLOSE (11:59 AM EDT)
2.35
0.08 (3.33%)
POST MARKET (AS OF 07:46 PM EDT)
Post Market
AS OF 07:46 PM EDT
2.35
0.08 (3.33%)
🟢Market: OPEN

INmune Bio Inc. Common stock (INMB) trades at $2.35 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place INMB at a fair price relative to peers.

Technical & fundamental data as of Aug 25, 2026.

Open?$2.40
High?$2.44
Low?$2.35
Prev. Close?$2.36
Volume?264.8K
Avg. Volume?424.2K
VWAP?$2.39
Rel. Volume?0.62x
Bid / Ask
Bid?$2.07 × 100
Ask?$2.76 × 100
Spread?$0.69
Midpoint?$2.42
Valuation & Ratios
Market Cap?65.5M
Shares Out?27.8M
Float?23.6M
Float %?88.8%
P/E Ratio?N/A
P/B Ratio?3.22
EPS?-$0.66
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Employees
21
Market Cap
65.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2019-02-04
Address
225 NE MIZNER BLVD, SUITE 640
BOCA RATON, FL 33432
Phone: (858) 964-3720
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
60
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.87Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.90%Elevated
Short Interest?2.1M
Days to Cover?5.0
Free Float23.6M
Avg Daily Volume421.8K
Settlement Date2026-08-14
Financial Health
Current Ratio?4.04Strong
Quick Ratio?4.04Strong
Cash Ratio?3.13Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
52
3.22FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.4CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-90.4%WEAK
ROA?
S&P
3
-68.6%WEAK
Cash Flow & Enterprise
FCF?$-15727000
Enterprise Value?$47.1M
Fundamentals ratios updated end of day